CAS 7756-96-9|butyl anthranilate
Introduction：Basic information about CAS 7756-96-9|butyl anthranilate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | butyl anthranilate | ||
|---|---|---|---|
| CAS Number | 7756-96-9 | Molecular Weight | 193.242 |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 297.1±13.0 °C at 760 mmHg |
| Molecular Formula | C11H15NO2 | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | 153.2±17.4 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | butyl anthranilate |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 297.1±13.0 °C at 760 mmHg |
| Molecular Formula | C11H15NO2 |
| Molecular Weight | 193.242 |
| Flash Point | 153.2±17.4 °C |
| Exact Mass | 193.110275 |
| PSA | 52.32000 |
| LogP | 3.63 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.540 |
| InChIKey | HUIYGGQINIVDNW-UHFFFAOYSA-N |
| SMILES | CCCCOC(=O)c1ccccc1N |
| Stability | Stability Air and light sensitive. Incompatible with alkalies, acids, strong oxidizing agents. |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | S26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | DG1527000 |
Articles2
More Articles| Mosquito odorant receptor for DEET and methyl jasmonate. Proc. Natl. Acad. Sci. U. S. A. 111(46) , 16592-7, (2014) Insect repellents are important prophylactic tools for travelers and populations living in endemic areas of malaria, dengue, encephalitis, and other vector-borne diseases. DEET (N,N-diethyl-3-methylbe... | |
| Stomatitis Associated With Use of mTOR Inhibitors: Implications for Patients With Invasive Breast Cancer. Clin. J. Oncol. Nurs. 19 , 468-74, (2015) The mammalian target of rapamycin (mTOR) inhibitor everolimus is approved (in combination with exemestane) for the treatment of postmenopausal women with advanced hormone receptor-positive, human epid... |
Synonyms
| MFCD00036506 |
| Butyl anthranilate |
| Benzoic acid, 2-amino-, butyl ester |
| EINECS 231-816-7 |
| Butyl 2-aminobenzoate |
